Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors

Clinical trial NCT02689219 · TERMINATED

Trial details

NCT number: NCT02689219
Sponsor: Nabil Adra
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Germ Cell Tumors Testis Cancer Testicular Cancer Embryonal Carcinoma Nonseminomatous Germ Cell Tumor

Start date: 2016-03-09
Primary completion: 2018-11-13
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.